{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:18:54Z","timestamp":1778879934013,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.transproceed.2024.05.039","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:09:58Z","timestamp":1721884198000},"page":"1280-1289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients"],"prefix":"10.1016","volume":"56","author":[{"given":"Caomei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li'an","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.05.039_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-9120(99)00101-0","article-title":"Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?","volume":"33","author":"Wieland","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0004","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/aor.13623","article-title":"Mycophenolates: the latest modern and potent immunosuppressive drugs in adult kidney transplantation: what we should know about them?","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0006","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3389\/fphar.2018.00908","article-title":"Pharmacokinetics of mycophenolate mofetil and development of limited sampling strategy in early kidney transplant recipients","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0009","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1053-2498(00)00191-1","article-title":"Mycophenolic acid concentrations are associated with cardiac allograft rejection","volume":"19","author":"DeNofrio","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-200002000-00004","article-title":"Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients","volume":"22","author":"Oellerich","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0011","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1097\/00007890-200006150-00018","article-title":"The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection","volume":"69","author":"Yamani","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-9120(00)00184-3","article-title":"Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients","volume":"34","author":"Shaw","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0013","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0014","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/dmd.32.8.775","article-title":"The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants","volume":"32","author":"Bernard","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0016","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1124\/dmd.106.010553","article-title":"Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid","volume":"34","author":"Bernard","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0017","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2174\/1389200219666171227201608","article-title":"Influence of genetic polymorphisms on mycophenolic acid pharmacokinetics and patient outcomes in renal transplantation","volume":"19","author":"Guo","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0018","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/pgs-2021-0087","article-title":"Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients","volume":"22","author":"Jiang","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0019","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/00498254.2020.1774682","article-title":"Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation","volume":"50","author":"Ling","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0166-0934(91)90126-K","article-title":"An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents","volume":"34","author":"Loparev","year":"1991","journal-title":"J Virol Methods"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0021","first-page":"1811","article-title":"Simultaneously determination of mycophenolic acid and two metabolites in the plasma of renal transplant patients LC-MS\/MS","volume":"19","author":"Jiang","year":"2021","journal-title":"Central South Pharmacy"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0022","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/dmd.104.001651","article-title":"Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0024","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/clinchem\/45.3.419","article-title":"Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil","volume":"45","author":"Sch\u00fctz","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-200310000-00011","article-title":"Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil","volume":"25","author":"Kuypers","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0026","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0027","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FTD.0b013e3181838063","article-title":"Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients","volume":"30","author":"Miura","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0028","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/FPC.0b013e32801430f8","article-title":"Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients","volume":"17","author":"Djebli","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0029","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/FTD.0b013e3182708f84","article-title":"UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients","volume":"34","author":"Fukuda","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/aps.2015.7","article-title":"Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients","volume":"36","author":"Xie","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/FTD.0b013e318180c709","article-title":"AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism","volume":"30","author":"van Agteren","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0032","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/clpt.2009.83","article-title":"UGT1A9 -275T>A\/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF\/tacrolimus-treated kidney transplant patients","volume":"86","author":"van Schaik","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13033","article-title":"Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: influence of genes and drugs","volume":"21","author":"Varnell","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0034","first-page":"379","article-title":"Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms","volume":"7","author":"Pithukpakorn","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0035","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/0091270009357429","article-title":"Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients","volume":"50","author":"Zhao","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0036","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00228-006-0248-2","article-title":"Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients","volume":"63","author":"Kagaya","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0037","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2217\/14622416.8.9.1127","article-title":"C-440T\/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation","volume":"8","author":"Baldelli","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0038","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/pgs-2018-0114","article-title":"Impact of UGT2B7 and ABCC2 genetic polymorphisms on mycophenolic acid metabolism in Chinese renal transplant recipients","volume":"19","author":"Li","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0039","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15287394.2017.1286922","article-title":"Association of UGT2B7, UGT1A9, ABCG2, and IL23R polymorphisms with rejection risk in kidney transplant patients","volume":"80","author":"Cili\u00e3o","year":"2017","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/phar.1928","article-title":"Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients","volume":"37","author":"Genvigir","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0041","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00002512-200118100-00004","article-title":"Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?","volume":"18","author":"Meier-Kriesche","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0042","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.tp.0000275423.69689.dc","article-title":"Immunosuppression of the elderly kidney transplant recipient","volume":"84","author":"Danovitch","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0043","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.transproceed.2007.02.082","article-title":"Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients","volume":"39","author":"Wang","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0044","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/0886022X.2015.1010442","article-title":"Variability of mycophenolic acid elimination in the renal transplant recipients \u2013 population pharmacokinetic approach","volume":"37","author":"Veli\u010dkovi\u0107-Radovanovi\u0107","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40620-020-00777-2","article-title":"Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study","volume":"34","author":"Bussalino","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0046","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13318-018-0506-6","article-title":"Longitudinal pharmacokinetics of mycophenolic acid in elderly renal transplant recipients compared to a younger control group: data from the nEverOld trial","volume":"44","author":"Romano","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0047","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bcp.13154","article-title":"The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients","volume":"83","author":"Tang","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0048","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1996.03636.x","article-title":"Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients","volume":"41","author":"Bullingham","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0049","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2125.2006.02841.x","article-title":"Time-dependent clearance of mycophenolic acid in renal transplant recipients","volume":"63","author":"van Hest","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2005101070","article-title":"Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients","volume":"17","author":"van Hest","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.05.039_bib0051","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jpba.2010.09.032","article-title":"In vitro influence of fatty acids and bilirubin on binding of mycophenolic acid to human serum albumin","volume":"54","author":"Vial","year":"2011","journal-title":"J Pharm Biomed Anal"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:15:29Z","timestamp":1724822129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0041134524003397"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.05.039","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}